GENE ONLINE|News &
Opinion
Blog

2026-04-07|

Sanjay Luthra Promoted to Lead Mattel’s Global Commercial Organization as Steve Totzke Departs

by GOAI
Share To

Mattel, Inc. has announced that Steve Totzke, the company’s President and Chief Commercial Officer, will be departing from his role. The company also revealed that Sanjay Luthra has been promoted to lead its Global Commercial Organization. These leadership changes mark a significant shift in the company’s executive team.

According to the announcement, Totzke’s departure comes after years of service with Mattel, during which he played a key role in overseeing commercial operations and driving growth strategies. Stepping into the position is Sanjay Luthra, who has been with Mattel for over two decades and most recently served as Executive Vice President and Managing Director for Europe, the Middle East, and Africa (EMEA). In his new role leading the Global Commercial Organization, Luthra will oversee worldwide sales and marketing efforts as part of Mattel’s ongoing strategy to strengthen its global presence.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 7, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Study Finds Non-Communicable Diseases Consume Large Portion of Household Income Among Elderly in India
2026-04-19
Study Identifies Antiviral Compounds in Egyptian Ziziphus spina-christi Effective Against Respiratory Viruses
2026-04-19
10x Genomics Introduces Atera Platform for Single-Cell Analysis and Spatial Biology
2026-04-18
Elevated Fetal Catecholamine Metabolites Linked to Growth Restriction in Sheep Model Study
2026-04-18
White House Issues Executive Order to Boost Research and Access to Psychedelic-Based Mental Health Therapies
2026-04-18
Comorbidities Linked to Higher Risks and Complications in Hip Fracture Surgery Outcomes
2026-04-18
20-Year Study Links Metabolically Healthy Obesity to Increased Long-Term Cardiovascular Disease Risk
2026-04-18
Scroll to Top